MARKET IS OPEN
Loading latest tickers...

Market Indices

S&P 500
$7,801.77
-0.22%
NASDAQ 100
$31,160.08
-0.21%
DOW JONES
$51,180.00
-0.66%
NASDAQ Composite
$27,538.69
-0.22%
RUSSELL 2000
$2,777.00
-1.29%
CBOE VIX
$15.08
+0.47%

Sector Heatmap

Technology-0.30%
Financials-0.48%
Healthcare+1.03%
Consumer Cycl-0.32%
Consumer Staples-0.12%
Energy-0.58%
Industrials-2.18%
Materials-1.51%
Real Estate-1.29%
Utilities-0.02%
Comm Services-0.35%

RCKT — Rocket Pharmaceuticals, Inc. Common Stock

Nasdaq

Rocket Pharmaceuticals, Inc. Common Stock

CompareBack to Screener
$2.54
+0.06(+2.22%)
O
2.45
H
2.64
L
2.42
V
2.81M
⏱️ End-of-day dataAs of Oct 7, 2026
OverviewStatisticsFinancialsHistorical DataOptionsDividend HistoryNewsChart

Chart

About RCKT

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. It has one reportable segment related to R&D and commercial readiness of its gene therapies.

IndustryPHARMACEUTICAL PREPARATIONS
SectorNot available
IPO DateFeb 18, 2015
Employees202
Stock ExchangeNasdaq
Ticker SymbolRCKT
Websitehttps://www.rocketpharma.com

Key Financial Statistics

Market Cap$281.02M
P/E RatioN/A
Dividend YieldNone
EPSN/A
BetaN/A
52-Week Range$2.42 - $5.45
52-Week Avg Volume2.47M
VWAP$2.55
Transactions14,335
Total Recorded Bars2,927 days